The Role of GABA A Receptor Subtypes in Benzodiazepine Abuse Liability
The Role of GABA A Receptor Subtypes in Benzodiazepine Abuse Liability
批准号:
8543694
负责人:
Uwe Rudolph
金额:
$7.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-15 至 2015-08-31
关键词:
Adverse effectsAffectAgonistAnxietyAnxiety DisordersArginineBehaviorBehavioralBenzodiazepinesBiological ModelsBrainCellsChemicalsChemosensitizationClinicalCognitive deficitsDementiaDependenceDevelopmentDiazepamFutureGABA AgentsGABA-A ReceptorGeneticHistidineImpaired cognitionIndividualKnock-in MouseKnowledgeMidazolamMolecular TargetMoodsMotivationMusMutant Strains MiceMutateNeuronsNucleus AccumbensOralPharmaceutical PreparationsPoint MutationProcessPropertyRattusRegulationReportingRewardsRoleSchizophreniaSelf AdministrationSelf StimulationSignal TransductionSleeplessnessSystemTestingVentral Tegmental AreaWorkbasecell typechronic paindopaminergic neurondrug developmentdrug of abusehippocampal pyramidal neuronin vivoneurobiological mechanismnovelprescription drug abusereceptorresponsezolpidem
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Benzodiazepines are among the most widely abused drugs, and like other drugs of abuse, they "hijack" the brain's dopaminergic reward system, in which several GABAA receptor subtypes are expressed in different neuronal cell types. The modulation of the reward system and of benzodiazepine self-administration by distinct GABAA receptor subtypes is only poorly understood. Here, we want to test the hypothesis that GABAA receptors bidirectionally modulate these behaviors. In the absence of chemical compounds which are truly specific for a GABAA receptor subtype, we propose to use a novel combined genetic and pharmacological approach to create a model system which will enable highly specific modulation of the activity of individual GABAA receptor subtypes. This will be achieved by using the non- selective benzodiazepine drugs diazepam and midazolam in triple point-mutated mice, in which these drugs are a true ?1-specific, ? 2-specific, ? 3-specific, or ? 5-specific full agonists, respectively. This system will make it possible to test whether potentiatio of a particular GABAA receptor subtype is sufficient for reward enhancement and benzodiazepine self-administration.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.neuropharm.2016.07.004
发表时间:
2016-10
期刊:
Neuropharmacology
影响因子:
4.7
作者:
[Ralvenius WT, Acuña MA, Benke D, Matthey A, Daali Y, Rudolph U, Desmeules J, Zeilhofer HU, Besson M]
通讯作者:
Besson M
DOI:
10.1038/ncomms7803
发表时间:
2015-04-13
期刊:
Nature communications
影响因子:
16.6
作者:
[Ralvenius WT, Benke D, Acuña MA, Rudolph U, Zeilhofer HU]
通讯作者:
Zeilhofer HU
Cellular mechanisms for age-related cognitive dysfunction and its pharmacological reversal: a strategy towards prevention and treatment of postoperative cognitive deficits in elderly patients
-
批准号:9926280
-
项目类别:
-
资助金额:$38.85万
-
财政年份:2019
-
负责人:Uwe Rudolph
-
依托单位:
Cellular mechanisms for age-related cognitive dysfunction and its pharmacological reversal: a strategy towards prevention and treatment of postoperative cognitive deficits in elderly patients
-
批准号:10152619
-
项目类别:
-
资助金额:$38.89万
-
财政年份:2019
-
负责人:Uwe Rudolph
-
依托单位:
Cellular mechanisms for age-related cognitive dysfunction and its pharmacological reversal: a strategy towards prevention and treatment of postoperative cognitive deficits in elderly patients
-
批准号:10407460
-
项目类别:
-
资助金额:$38.85万
-
财政年份:2019
-
负责人:Uwe Rudolph
-
依托单位:
Neurobiological relevance of 9p24.1 CNVs for bipolar disorder and schizophrenia
-
批准号:8754996
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2014
-
负责人:Uwe Rudolph
-
依托单位:
A GABA Pathway to Faster Acting Antidepressants
-
批准号:8811471
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2012
-
负责人:Uwe Rudolph
-
依托单位:
A GABA Pathway to Faster Acting Antidepressants
-
批准号:8616813
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2012
-
负责人:Uwe Rudolph
-
依托单位:
A GABA Pathway to Faster Acting Antidepressants
-
批准号:9016574
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2012
-
负责人:Uwe Rudolph
-
依托单位:
Emotional regulation: Modeling GABA A receptor subtype specific agents in mice
-
批准号:8242894
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2012
-
负责人:Uwe Rudolph
-
依托单位:
The Role of GABA A Receptor Subtypes in Benzodiazepine Abuse Liability
-
批准号:8278153
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2012
-
负责人:Uwe Rudolph
-
依托单位:
A GABA Pathway to Faster Acting Antidepressants
-
批准号:8371318
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2012
-
负责人:Uwe Rudolph
-
依托单位:
A GABA Pathway to Faster Acting Antidepressants
-
批准号:8484449
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2012
-
负责人:Uwe Rudolph
-
依托单位:
Emotional regulation: Modeling GABA A receptor subtype specific agents in mice
-
批准号:8409823
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2012
-
负责人:Uwe Rudolph
-
依托单位:
Generation of etiological models for schizophrenia by chromosome engineering
-
批准号:7896896
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2010
-
负责人:Uwe Rudolph
-
依托单位:
Generation of etiological models for schizophrenia by chromosome engineering
-
批准号:8047994
-
项目类别:
-
资助金额:$23.46万
-
财政年份:2010
-
负责人:Uwe Rudolph
-
依托单位:
Regional actions of general anesthetics in inhibitory hippocampal networks
-
批准号:8018632
-
项目类别:
-
资助金额:$44.73万
-
财政年份:2009
-
负责人:Uwe Rudolph
-
依托单位:
GABAA subtype-specific pharmacological modulation of reward-related behavior
-
批准号:7739969
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2009
-
负责人:Uwe Rudolph
-
依托单位:
GABAA subtype-specific pharmacological modulation of reward-related behavior
-
批准号:7895004
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2009
-
负责人:Uwe Rudolph
-
依托单位:
Antidepressant-like and reward-related functions of a2-containing GABAA receptors
-
批准号:7806641
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2009
-
负责人:Uwe Rudolph
-
依托单位:
Genetic Mapping of Neuronal Circuits Involved in Regulation of Anxiety and Fear
-
批准号:7902081
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2009
-
负责人:Uwe Rudolph
-
依托单位:
Regional actions of general anesthetics in inhibitory hippocampal networks
-
批准号:7787501
-
项目类别:
-
资助金额:$45.24万
-
财政年份:2009
-
负责人:Uwe Rudolph
-
依托单位:
海外基金